TenderDekho Logo
GEM

Contract Bidding Open For Budesunide 1 mg Respules,Chlorzoxazone 500mg Plus Diclofenac Sodium 50mg Plus PCM 325 mg Tab,Hydroc in CENTRAL DELHI, DELHI

Bid Publish Date

26-May-2025, 12:56 pm

Bid End Date

16-Jun-2025, 1:00 pm

Value

₹53,903

Progress

Issue26-May-2025, 12:56 pm
Technical06-Dec-2025, 12:45 pm
AwardCompleted
Explore all 5 tabs to view complete tender details

Quantity

28940

Bid Type

Two Packet Bid

Categories 8

A tender has been published for Indian Army Budesunide 1 mg Respules, Chlorzoxazone 500mg Plus Diclofenac Sodium 50mg Plus PCM 325 mg Tab, Hydrocortisone 5 mg Tab, Albendazole Syp Each 5ml containing 200 mg bott of 10 ml, Tab Amitriptyline 25 mg, Clotrimazole mouth paint 1percent bottle of 15 ml in CENTRAL DELHI, DELHI. Quantity: 28940 by. Submission Deadline: 16-06-2025 13: 00: 00. Check eligibility and apply.

Documents 5

GeM-Bidding-7888465.pdf

Main Document

BOQ Document

BOQ

BOQ Document

BOQ

Buyer uploaded ATC document

ATC

GEM General Terms and Conditions Document

GEM_GENERAL_TERMS_AND_CONDITIONS

Past Similar Tenders (Historical Results)

5 found

Syrup terbutaline sulphate 1point 25 mg plus bromhexine hcl 4mg plus guaiphenesin 50 mg per 5 ml bo

Indian Army

DEHRADUN, UTTARAKHAND

Posted: 13 January 2026
Closed: 23 January 2026
GEM

Chlorhexidine 0 point 2 percent WV Mouth Wash Bott of 160 ml,Clopidogrel 75 mg Tab,Amlodipine Besyl

Indian Army

AMRITSAR, PUNJAB

Posted: 12 September 2025
Closed: 23 September 2025
GEM

BROMHEXINE 100 ML SYP,BUDESONIDE 1 MF RESPULES,CABERGOLINE 0.5 MG TAB,CALAMINE LOTION 100 ML,CALAMI

Indian Army

PATIALA, PUNJAB

Posted: 18 December 2024
Closed: 8 January 2025
GEM

CHLORZOXAZONE 500 MG PLUS DICLOFENAC SODIUM 50 MG PLUS PARACETAMOL 325 MG TAB,ALBENDAZOLE 400 MG TA

Indian Army

ANANTHNAG, JAMMU & KASHMIR

Posted: 21 September 2025
Closed: 1 October 2025
GEM

Indian Army Medical Supplies Tender 2026 India - 9 Medicines & Topical Preparations Supply, 49310 Estimated Value

Indian Army

Posted: 17 January 2026
Closed: 27 January 2026
GEM

Bill of Quantities (BOQ) 6 Items

Item # Title Description Quantity Unit Consignee Delivery (Days)
1 Budesunide 1 mg Respules Budesunide 1 mg Respules 1,200 no [email protected] 15
2 Chlorzoxazone 500mg Plus Diclofenac Sodium 50mg Plus PCM 325 mg Tab Chlorzoxazone 500mg Plus Diclofenac Sodium 50mg Plus PCM 325 mg Tab 26,000 no [email protected] 15
3 Hydrocortisone 5 mg Tab Hydrocortisone 5 mg Tab 300 no [email protected] 15
4 Albendazole Syp Each 5ml containing 200 mg bott of 10 ml Albendazole Syp Each 5ml containing 200 mg bott of 10 ml 180 bott [email protected] 15
5 Tab Amitriptyline 25 mg Tab Amitriptyline 25 mg 1,200 no [email protected] 15
6 Clotrimazole mouth paint 1percent bottle of 15 ml Clotrimazole mouth paint 1% bottle of 15 ml 60 bott [email protected] 15

Required Documents

1

Experience Criteria

2

Past Performance

3

Bidder Turnover

4

Certificate (Requested in ATC)

5

OEM Authorization Certificate

6

OEM Annual Turnover

7

Additional Doc 1 (Requested in ATC)

8

Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria

9

the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer

Technical Results

S.No Seller Item Date Status
1DEVYA AGENCIES   Under PMA-12-06-2025 12:45:21Evaluated
2FAIRDEAL HEALTH CARE PRIVATE LIMITED   Under PMA-16-06-2025 12:52:50Evaluated
3JVB MEDICARE PRIVATE LIMITED   Under PMA-14-06-2025 18:09:50Evaluated
4PUSHYA MEDISURG   Under PMA-14-06-2025 16:35:15Evaluated
5REKIN PHARMA PRIVATE LIMITED   Under PMA-13-06-2025 21:09:19Evaluated
6SB LIFESCIENCES PRIVATE LIMITED   Under PMA-14-06-2025 12:47:05Evaluated
7SHRISHTI PHARMACEUTICAL & SURGICALS   Under PMA-14-06-2025 13:05:27Evaluated
8SMPL LIFE SCIENCES PRIVATE LIMITED   Under PMA-16-06-2025 10:24:07Evaluated
9SRI G PHARMACEUTICALS   Under PMA-05-06-2025 12:47:40Evaluated
10SRI SAI AGENCIES   Under PMA-16-06-2025 10:31:41Evaluated
11SUKUN PHARMA   Under PMA-09-06-2025 13:28:04Evaluated
12VANDANA MEDICO TRADERS   Under PMA-16-06-2025 12:43:56Evaluated

Frequently Asked Questions

Key insights about DELHI tender market

What are the eligibility requirements for participating in this tender?

The eligibility requirements include being a registered entity with a valid license to operate in the pharmaceutical industry. Bidders must also demonstrate experience in providing similar medical products and comply with all applicable regulatory standards. Ensuring proper documentation that certifies your capability to deliver the specified products is critical for qualification.

What certifications are required to bid on this tender?

Bidders must provide a range of required certificates, including the manufacturer's license, quality assurance certifications such as ISO certifications, and any relevant compliance documents. It’s essential to ensure that all certificates are current and applicable to the products being offered in the bid.

How should documents be submitted for this tender?

The submission methods require all documents to be uploaded electronically through the designated procurement portal. This includes formal quotes, compliance certifications, and other relevant documentation. Ensure all files are in accepted formats such as PDF or DOCX to avoid issues during the submission process.

What kinds of testing criteria will be used for evaluation?

The testing criteria will examine the quality, safety, and efficacy of the supplied medical products. Bidders must provide documentation that proves their products meet or exceed industry quality standards. This will include testing results and compliance with any applicable regulatory mandates for pharmaceuticals.

What benefits exist for MSEs participating in this tender?

Micro, Small, and Medium Enterprises (MSEs) are presented with various benefits in this tendering process. This includes relaxed eligibility criteria and financial incentives aimed at promoting MSE participation, thereby enabling them to compete effectively. Additionally, there are provisions in support of 'Make in India' policies that encourage local manufacturing.